The global impact and cost-effectiveness of a melioidosis vaccine

BACKGROUND: Every year, 90,000 people may die from melioidosis. Vaccine candidates have not proceeded past animal studies, partly due to uncertainty around the potential market size. This study aims to estimate the potential impact, cost-effectiveness and market size for melioidosis vaccines. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Luangasanatip, Nantasit, Flasche, Stefan, Dance, David A. B., Limmathurotsakul, Direk, Currie, Bart J., Mukhopadhyay, Chiranjay, Atkins, Tim, Titball, Richard, Jit, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610909/
https://www.ncbi.nlm.nih.gov/pubmed/31272431
http://dx.doi.org/10.1186/s12916-019-1358-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610909/
https://www.ncbi.nlm.nih.gov/pubmed/31272431
http://dx.doi.org/10.1186/s12916-019-1358-x

Ejemplares similares